Dr. Pamela M. Ling, MD

Dr. Ling practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Ling's NPI, 1871557827, was assigned on April 14, 2006. Dr. Ling graduated from UCSF School of Medicine in 1996. Dr. Ling holds California license A65590.

Dr. Ling's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Ling's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Ling to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ling practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ling's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ling is board certified in internal medicine by the American Board of Internal Medicine. Dr. Ling is licensed in California.

Dmand AI lists acute kidney failure, alcohol use disorders, atrial fibrillation and flutter, bursitis, cardiomyopathy, chronic diabetes, chronic hypertension and chronic inflammatory bowel disease (IBD) among the conditions Dr. Ling treats.

CMS data shows 147 Medicare services from Dr. Ling across 3 procedure codes in 2024, for 96 Medicare patients. Medicare paid $10,427 for them. Every service was in an office.

CMS counts 96 Medicare patients who saw Dr. Ling in 2024. The largest group is 65 to 74, with 48 patients. 72% of them have high cholesterol, and 61% have high blood pressure. 47% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ling's median patient age at 66, with 62% women.

In 2024, Dr. Ling wrote 1,275 Medicare Part D claims for 153 patients. 88% of them were for generic drugs. CMS names the drug for 803 of them, across 32 drugs with 11 or more claims each, at $14,705 in total drug cost. In 2023, CMS named 726 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Ling for performance year 2024, reported as part of a group. Dr. Ling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ling as offering telehealth.

Dmand AI links 190 papers to Dr. Ling, published from 2006 to 2025. 2024 was the busiest year, with 15. The most frequent topics are Smoking, Electronic Nicotine Delivery Systems and Tobacco Products. Dr. Ling has published most often in Tob Control. Dr. Ling's most frequent co-authors are Beth Ellen Cohen, MD, Salomeh Keyhani, MD and Nan Jiang, MD.

Dmand AI links Dr. Ling to 2 clinical trials. Conditions studied include Smoking, Tobacco Use Cessation and Behavior. University of California, San Francisco sponsors the most, 2.

Dmand AI lists 1 award for Dr. Ling, most recently CMS Stage 1 EHR in 2013.

Dr. Ling graduated from UCSF School of Medicine in 1996.

Dr. Ling is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.